CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 350 enrolled
Drug / intervention
No interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01828333
NCT01828333N/ACompleted
CompareCT.gov

Treatment of Severe Malaria - An Operational Comparative Study Between Quinine and Artesunate for the Treatment of Severe Malaria in Hospitals and Health Centers of Kinshasa and Lower Congo

Swiss Tropical & Public Health Institute·observational·Posted Apr 10, 2013·Updated Sep 13, 2013

In Brief

An observational study evaluating No intervention for Severe Malaria. Completed, enrolled 350 participants across 9 sites.

Detailed Summary

The MATIAS study aims to demonstrate through limited scope implementation studies how injectable artesunate may be progressively rolled out nationwide in the Democratic Republic of the Congo as the preferred treatment for severe malaria.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSevere Malaria
CountriesDemocratic Republic of the Congo
CollaboratorsMedicines for Malaria Venture

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedApr 10, 2013
Enrollment StartApr 1, 2013
Primary CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 13.2 years ago

Interventions

No interventionother

No intervention